Article - 03/12/2012 Early pollutant warning system for sewage plants Technologies that can help identify pollutants in the wastewater treated in sewage plants are urgently needed. LimCo International GmbH might have a solution. The Konstanz-based company has developed a fully-automated early warning system for monitoring the quality of water and sediment in sewage plants and waterworks. https://www.biooekonomie-bw.de/en/articles/news/early-pollutant-warning-system-for-sewage-plants
Article - 03/12/2012 DFG strengthens Ulm research into ageing with new research training group The German Research Foundation (DFG) has recently granted Ulm University funding for a research training group (RTG) into ”Cellular and Molecular Mechanisms of Ageing”. This again confirms the strength of ageing research at Ulm University. The granting of funds totalling three million euros over a period of four and a half years is an important indication of the continued strength of the small university, particularly as many were worried that…https://www.gesundheitsindustrie-bw.de/en/article/news/dfg-strengthens-ulm-research-into-ageing-with-new-research-training-group
Article - 03/12/2012 Differences between white, brown and “brite” fat tissue The latest results on the different metabolic pathways used by white and brown fat cells and potential transformations between the two cell types were discussed at the conference “Metabolism 2012: From Signalling to Disease” held on 15th and 16th November 2012 in Heidelberg. A special cell type, so-called “brite” adipocytes, may have the potential to be used in the treatment of obesity and related metabolic diseases such as diabetes.https://www.gesundheitsindustrie-bw.de/en/article/news/differences-between-white-brown-and-brite-fat-tissue
Press release - 29/11/2012 Neural interaction in periods of silence While in deep dreamless sleep our hippocampus sends messages to our cortex and changes its plasticity possibly transferring recently acquired knowledge to long-term memory. But how exactly is this done? Scientists from the Max Planck Institute for Biological Cybernetics have now developed a novel multimodal methodology called neural event-triggered functional magnetic resonance imaging NET-fMRI and presented the very first results obtained using…https://www.gesundheitsindustrie-bw.de/en/article/press-release/neural-interaction-in-periods-of-silence
Press release - 26/11/2012 Project "DiscoGnosis" aims to develop a rapid malaria test An estimated 220 million people become infected with malaria each year the disease is often lethal. The infected suffer from a high fever. As this is also the case with other germs however it is important to conduct a rapid and precise analysis to determine the cause of the disease for a successful therapy. A team of researchers aims to develop a rapid test of this kind within the context of the project DiscoGnosis. The project is being…https://www.gesundheitsindustrie-bw.de/en/article/press-release/project-discognosis-aims-to-develop-a-rapid-malaria-test
Guest article - 26/11/2012 Field report: five months in Shanghai I spent five months from June to November 2012 at the Chinese Academy of Sciences Shanghai Institute of Biological Sciences and Cell Biology. This stay was made possible by a grant I received from the Baden-Württemberg Ministry of Science Research and the Arts. I spent five months working in the laboratory of Professor Xu on a project aimed at deciphering the process of T-cell receptor signalling. https://www.gesundheitsindustrie-bw.de/en/article/news/field-report-five-months-in-shanghai
Press release - 26/11/2012 Functional Magnetic Resonance Imaging under the Magnifying Glass Jozien Goense from the Max Planck Institute for Biological Cybernetics in Tübingen Germany and her colleagues used functional Magnetic Resonance Imaging fMRI to observe these layer-specific neural processes within the cortex and found different mechanisms for fMRI response increases and decreases as well as cortical layer-dependent differences in the neurovascular coupling mechanism. https://www.gesundheitsindustrie-bw.de/en/article/press-release/functional-magnetic-resonance-imaging-under-the-magnifying-glass
Article - 26/11/2012 Membrane proteins in the mitochondria do more than just generate cellular energy The proteins in the membranes of the mitochondria are complex machines in the nanoworld that mediate the oxygen-coupled generation of energy in cells. Their role in this process is not yet understood in detail. However, the proteins’ intractability has not discouraged Prof. Dr. Carola Hunte’s research group at the University of Freiburg. The group is using state-of-the-art methods to look deep into the proteins’ active centres and decipher the…https://www.gesundheitsindustrie-bw.de/en/article/news/membrane-proteins-in-the-mitochondria-do-more-than-just-generate-cellular-energy
Dossier - 26/11/2012 Genetic diagnostics: technology reaches the limits of what is medically reasonable Rapid progress in sequencing technologies is poised to set the imagination of biomedical researchers on fire. Experts now believe that progress is about to make possible what seemed to be utopian a few years ago – it seems likely that it will soon be possible to sequence the human genome in only a few minutes and store and automatically analyse it using tiny automates. However, is everything that is technically feasible also reasonable?https://www.gesundheitsindustrie-bw.de/en/article/dossier/genetic-diagnostics-technology-reaches-the-limits-of-what-is-medically-reasonable
Press release - 26/11/2012 Textile pressure ulcer prevention Immobile patients are in constant danger of developing pressure ulcers on the skin. Empa, Schoeller Medical and the Swiss Paraplegic Centre have worked together to develop a special sheet that is gentle on the skin and helps to make patients more comfortable.https://www.gesundheitsindustrie-bw.de/en/article/press-release/textile-pressure-ulcer-prevention
Press release - 22/11/2012 Mechanism to Repair Clumped Proteins Explained Clumped proteins can be dissolved with the aid of cellular repair systems a process of critical importance for cell survival especially under conditions of stress. Heidelberg researchers have now decrypted the fundamental mechanism for dissolving protein aggregates that involves specific molecular chaperones.https://www.gesundheitsindustrie-bw.de/en/article/press-release/mechanism-to-repair-clumped-proteins-explained
Press release - 22/11/2012 CeGaT and Genomatix are finalists of Boston Children’s Hospital’s CLARITY challenge CeGaT (Center for Genomics and Transcriptomics) GmbH, the Department of Prostate Cancer Research, Institute of Pathology, University Hospital Bonn and Genomatix Software GmbH were announced as finalist (Top 3) of the CLARITY challenge, organized by Boston Children’s Hospital.https://www.gesundheitsindustrie-bw.de/en/article/press-release/cegat-and-genomatix-are-finalists-of-boston-children-s-hospital-s-clarity-challenge
Article - 19/11/2012 Uncovering the genetics of prostate cancer The prostate genome project, which is part of the International Cancer Genome Consortium, is focused on the genetic and epigenetic causes of the development and progression of this highly variable cancer and finding markers that enable the reliable diagnosis of the disease. The German research groups involved in the project are coordinated by the German Cancer Research Center and concentrate on prostate cancer patients under 50 years of age, as…https://www.gesundheitsindustrie-bw.de/en/article/news/uncovering-the-genetics-of-prostate-cancer
Article - 19/11/2012 Biopharm GmbH: growth factors for use in regenerative medicine With more than 26 years’ experience in the field of orthopaedics, dermatology and personalised medicine, the Heidelberg-based biotechnology company Biopharm GmbH is firmly established in the regenerative medicine market. Based on its proprietary growth factor technology platform, Biopharm develops innovative methods for the treatment of bone and cartilage damage and improvement of the wound healing process.https://www.gesundheitsindustrie-bw.de/en/article/news/biopharm-gmbh-growth-factors-for-use-in-regenerative-medicine
Press release - 16/11/2012 ERC Advanced Grant for immunobiologist from the University of Freiburg Prof. Dr. Michael Reth has been awarded an Advanced Grant of the European Research Council ERC. The 2.24 million Euro award will be used to fund research over the next 5 years. The Albert-Ludwigs-University scientist wants to use this special funding to explore the nanoscale organization of proteins in biological membranes. With his nanoscale explorer program Reth and his group wish to obtain new insights into membrane processes of normal and…https://www.gesundheitsindustrie-bw.de/en/article/press-release/erc-advanced-grant-for-immunobiologist-from-the-university-of-freiburg
Press release - 16/11/2012 GATC Biotech is partner in decoding the genome of the pathogen Colletotrichum In collaboration with the Max Planck Institute (MPI) for Plant Breeding Research in Cologne GATC Biotech AG has decoded the genome of the fungal pathogen Colletotrichum higginsianum. The recently published results show that gene expression plays a decisive role in plant disease. With this knowledge the international project aims to improve plant protection from this pest.https://www.biooekonomie-bw.de/en/articles/pm/gatc-biotech-is-partner-in-decoding-the-genome-of-the-pathogen-colletotrichum
Press release - 15/11/2012 How bacteria attack their host cells with sticky lollipops Yersinia enterocolitica, a pathogenic bacterium, causes fever and diarrhea. By help of a protein anchored in its membrane, Yersinia attaches to its host cells and infects them. Scientists of the Max Planck Institute for Developmental Biology in Tübingen and the Leibniz-Institut fuer Molekulare Pharmakologie in Berlin have determined the structure of an important component of the membrane protein and have gained insight into its biogenesis. The…https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-bacteria-attack-their-host-cells-with-sticky-lollipops
Press release - 13/11/2012 immatics’ renal cancer vaccine IMA901 completes phase 3 patient recruitment immatics biotechnologies GmbH announced that it has completed patient recruitment into the pivotal phase 3 trial evaluating its lead cancer vaccine IMA901 for renal cell carcinoma RCC. The first interim overall survival results are expected during the first half of 2014.https://www.gesundheitsindustrie-bw.de/en/article/press-release/immatics-renal-cancer-vaccine-ima901-completes-phase-3-patient-recruitment
Article - 12/11/2012 Otmar D. Wiestler – combining excellent research and cancer medicine The University of Tübingen Medical Faculty’s award of an honorary doctorate to the Chairman of the Executive Board of the German Cancer Research Center, Professor Dr. Otmar D. Wiestler, was not just a distinction awarded to a renowned neuropathologist, oncologist and stem cell researcher, it also honoured a well-known personality who has made a significant contribution to shaping health research in Germany.https://www.gesundheitsindustrie-bw.de/en/article/news/otmar-d-wiestler-combining-excellent-research-and-cancer-medicine
Press release - 12/11/2012 Phosphate switch to fine-tune the protein production in cells MicroRNAs are essential regulators of the genetic program in multicellular organisms. Because of their potent effects the production of these small regulators has itself to be tightly controlled. That is the key finding of a new study performed by Tübingen scientists at the Max Planck Institute for Developmental Biology. They identified a new component that modulates the production of microRNAs in thale cress by the removal of phosphate residues…https://www.gesundheitsindustrie-bw.de/en/article/press-release/phosphate-switch-to-fine-tune-the-protein-production-in-cells
Article - 12/11/2012 HANDTE Umwelttechnik GmbH – a system provider of energy-efficient exhaust air purification solutions The purification of exhaust air, a classical technology for end-of-pipe environmental protection, is commonly used in cases when industrial processes result in malodorous exhaust air or air contaminated with hazardous substances. HANDTE Umwelttechnik GmbH started specialising in such solutions way back in 1889.https://www.biooekonomie-bw.de/en/articles/news/handte-umwelttechnik-gmbh-a-system-provider-of-energy-efficient-exhaust-air-purification-solutions
Press release - 12/11/2012 GATC Biotech joins a new EU research network for young researchers Seven European research institutions and GATC Biotech have formed a consortium providing cutting-edge training in the scientific study of the human past. The BEAN (Bridging the European and Anatolian Neolithic) Initial Training Network has been awarded four years of funding from the European Commission through the Marie Curie Actions program. It is a new multinational and multidisciplinary Marie Curie Research initiative exploring the origins of…https://www.gesundheitsindustrie-bw.de/en/article/press-release/gatc-biotech-joins-a-new-eu-research-network-for-young-researchers
Article - 12/11/2012 Autoimmune diseases – when the body sheds its skin Most people believe that snakes and insects are the only animals able to shed their skin. However autoimmune diseases of the largest human organ i.e. the skin can have a similar effect by creating blisters scars peeling and wet wounds. Dr. Cassian Sitaru from the University of Freiburg Medical Centre specifically focuses on blistering autoimmune dermatoses. Using disease models in Petri dishes and laboratory mice Sitaru and his team hope to find…https://www.gesundheitsindustrie-bw.de/en/article/news/autoimmune-diseases-when-the-body-sheds-its-skin
Press release - 12/11/2012 Searching for new strategies against prostate cancer The European Research Council (ERC) has announced that Roland Schüle, Scientific Director at the Department of Urology, University of Freiburg Medical Centre has been awarded an ERC Advanced Grant. Professor Schüle will receive €2.5 million for a period of 5 years for his research proposal to identify and characterize the molecular and physiological functions of the epigenetic enzyme LSD1 and to explore its role in prostate cancer.https://www.gesundheitsindustrie-bw.de/en/article/press-release/searching-for-new-strategies-against-prostate-cancer